Table: Daito -2015/16 parent results
Jul 12 (Reuters)-
Daito Pharamaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2016 May 31, 2015 May 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 36.23 33.91
(+6.8 pct) (+9.2 pct)
Operating 3.25 3.22
(+0.9 pct) (+33.5 pct)
Recurring 3.42 3.25
(+5.2 pct) (+34.0 pct)
Net 2.38 2.11
(+12.4 pct) (+35.5 pct)
EPS 189.97 yen 172.75 yen
Ann Div 30.00 yen 30.00 yen 30.00 yen
-Q2 Div 15.00 yen 15.00 yen 15.00 yen
-Q4 Div 15.00 yen 15.00 yen 15.00 yen
NOTE - Daito Pharamaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Daito Pharmaceutical
See all newsTo Buy Back Up To 4.4% Of Own Shares Worth 2 Billion Yen
Table: Daito Pharmaceutical -Q1 group results
Execution Of JV And Share Transfer Agreement For Transfer Of Kyorin Pharmaceutical's Generic Drug Business To JV By Daito, Meiji Seika Pharma And Dbj
Table: Daito -2025/26 parent results
Table: Daito -2025/26 group results